AbCellera Biologics Inc. <ABCL.O>: BMO raises target price to $15 from $7
ABCL•Related News
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
KLRS•
Imunon Q2 FY26 net loss widens to $2.8 million
IMNN•
RingCentral management to speak at Oppenheimer Technology, Internet & Communications Conference
RNG•
Clearmind Medicine reports positive permeation results for intranasal MEAI formulation study
CMND•
Collective Mining begins trading on Nasdaq after NYSE American delisting
CNL•